Phenotypic malignant changes and untargeted lipidomic analysis of long-term exposed prostate cancer cells to endocrine disruptors

Environmental Research

Volumn 140, Issue , 2015, Pages 18-31

  Bedia, Carmen ^a   Dalmau, Núria ^a   Jaumot, Joaquim ^a   Tauler, Romà ^a  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Chemometrics; Chronic exposure; Endocrine disruptors; Prostate cancer; Untargeted lipidomics

Indexed keywords

ALDRIN; AROCLOR 1254; CARDIOLIPIN; CHLORPYRIFOS; GELATINASE A; GLYCOSPHINGOLIPID; PHOSPHOLIPID; SPHINGOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; ENDOCRINE DISRUPTOR; LIPID; PRIMER DNA;

CANCER; ENDOCRINE DISRUPTOR; HORMONE; LIPID; MENS HEALTH; PHENOTYPE; TRANSFORMATION; TUMOR;

ARTICLE; CARCINOGENESIS; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOMETRIC ANALYSIS; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPIDOMICS; LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; ZYMOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; ENDOCRINE DISRUPTORS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIPIDS; MALE; MASS SPECTROMETRY; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84925390156     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.03.014     Document Type: Article

References (73)

1. Alavanja M.C., Samanic C., Dosemeci M., Lubin J., Tarone R., Lynch C.F., Knott C., Thomas K., Hoppin J.A., Barker J., Coble J., Sandler D.P., Blair A. Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am. J. Epidemiol. 2003, 157:800-814.
2. Angioni A., Dedola F., Garau A., Sarais G., Cabras P., Caboni P. Chlorpyrifos residues levels in fruits and vegetables after field treatment. J. Environ. Sci. Health B 2011, 46:544-549.
3. Bell M.R. Endocrine-disrupting actions of PCBs on brain development and social and reproductive behaviors. Curr. Opin. Pharmacol. 2014, 19C:134-144.
4. Bates R.C., Mercurio A.M. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell 2003, 14:1790-1800.
5. Bruntz R.C., Lindsley C.W., Brown H.A. Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer. Pharmacol. Rev. 2014, 66:1033-1079.
6. Birkle S., Zeng G., Gao L., Yu R.K., Aubry J. Role of tumor-associated gangliosides in cancer progression. Biochimie 2003, 85:455-463.
7. Cillo F., de Eguileor M., Gandolfi F., Brevini T.A. Aroclor-1254 affects mRNA polyadenylation, translational activation, cell morphology, and DNA integrity of rat primary prostate cells. Endocr. Relat. Cancer 2007, 14:257-266.
8. Cordella C.B.Y., Bertrand D. SAISIR: A new general chemometric toolbox. TrAC-Trends in Anal. Chem. 2014, 54:75-82.
9. Derouiche S., Warnier M., Mariot P., Gosset P., Mauroy B., Bonnal J.L., Slomianny C., Delcourt P., Prevarskaya N., Roudbaraki M. Bisphenol A stimulates human prostate cancer cell migration remodelling of calcium signalling. Springerplus 2013, 2:54.
10. Dumas J.F., Peyta L., Couet C., Servais S. Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia. Biochimie 2013, 95:27-32.
11. El Majidi N., Bouchard M., Carrier G. Systematic analysis of the relationship between standardized biological levels of polychlorinated biphenyls and thyroid function in pregnant women and newborns. Chemosphere 2014, 98:1-17.
12. Eilers P.H. A perfect smoother. Anal. Chem. 2003, 75:3631-3636.
13. Edmond V., Dufour F., Poiroux G., Shoji K., Malleter M., Fouque A., Tauzin S., Rimokh R., Sergent O., Penna A., Dupuy A., Levade T., Theret N., Micheau O., Segui B., Legembre P. Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility. Oncogene 2014.
14. Farrés M., Piña B., Tauler R. Chemometric evaluation of Saccharomyces cerevisiae metabolic profiles using LC-MS. Metabolomics 2014.
15. Foster D.A., Xu L. Phospholipase D in cell proliferation and cancer. Mol. Cancer Res. 2003, 1:789-800.
16. Fhaner C.J., Liu S., Ji H., Simpson R.J., Reid G.E. Comprehensive lipidome profiling of isogenic primary and metastatic colon adenocarcinoma cell lines. Anal. Chem. 2012, 84:8917-8926.
17. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53(Suppl 1):S43-S50.
18. Grandjean P., Landrigan P.J. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014, 13:330-338.
19. Guerini V., Sau D., Scaccianoce E., Rusmini P., Ciana P., Maggi A., Martini P.G., Katzenellenbogen B.S., Martini L., Motta M., Poletti A. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res. 2005, 65:5445-5453.
20. Gemperline P. Practical Guide to Chemometrics 2006, CRC Press. Taylor & Francis Group, Boca Raton.
21. Gorrochategui E., Casas J., Porte C., Lacorte S., Tauler R. Chemometric strategy for untargeted lipidomics: biomarker detection and identification in stressed human placental cells. Anal. Chim. Acta 2015, 854:20-33.
22. Grun F., Watanabe H., Zamanian Z., Maeda L., Arima K., Cubacha R., Gardiner D.M., Kanno J., Iguchi T., Blumberg B. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol. 2006, 20:2141-2155.
23. Hooker E.P., Fulcher K.G., Gibb H.J. Aldrin and dieldrin: a reevaluation of the cancer and noncancer dose-response assessments. Risk Anal. 2014, 34:865-878.
24. Hessel P.A., Kalmes R., Smith T.J., Lau E., Mink P.J., Mandel J. A nested case-control study of prostate cancer and atrazine exposure. J. Occup. Environ. Med. 2004, 46:379-385.
25. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
26. Hatano K., Miyamoto Y., Nonomura N., Kaneda Y. Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-kappaB-dependent transcriptional control of alpha2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells. Int. J. Cancer 2011, 129:1838-1847.
27. Hardy S., El-Assaad W., Przybytkowski E., Joly E., Prentki M., Langelier Y. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J. Biol. Chem. 2003, 278:31861-31870.
28. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
29. Jeng H.A. Exposure to endocrine disrupting chemicals and male reproductive health. Front Public Health 2014, 2:55.
30. Jaumot J., Gargallo R., de Juan A., Tauler R. A graphical user-friendly interface for MCR-ALS: a new tool for multivariate curve resolution in MATLAB. Chemom. Intell. Lab. Syst. 2005, 76:101-110.
31. Jaumot J., de Juan A., Tauler R. MCR-ALS GUI 2.0: New features and applications. Chemom. Intell. Lab. Sys. 2015, 140:1-12.
32. Knower K.C., To S.Q., Leung Y.K., Ho S.M., Clyne C.D. Endocrine disruption of the epigenome: a breast cancer link. Endocr. Relat. Cancer 2014, 21:T33-T55.
33. Kajta M., Wojtowicz A.K. Impact of endocrine-disrupting chemicals on neural development and the onset of neurological disorders. Pharmacol. Rep. 2013, 65:1632-1639.
34. Koutros S., Beane Freeman L.E., Lubin J.H., Heltshe S.L., Andreotti G., Barry K.H., DellaValle C.T., Hoppin J.A., Sandler D.P., Lynch C.F., Blair A., Alavanja M.C. Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study. Am. J. Epidemiol. 2013, 177:59-74.
35. Kling D., Kunkle J., Roller A.S., Gamble W. Polychlorinated biphenyls: in vivo and in vitro modifications of cholesterol and fatty acid biosynthesis. J. Environ. Pathol. Toxicol. 1978, 1:813-828.
36. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
37. Kartal Yandim M., Apohan E., Baran Y. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer. Cancer Chemother. Pharmacol. 2013, 71:13-20.
38. Kiebish M.A., Han X., Cheng H., Chuang J.H., Seyfried T.N. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J. Lipid Res. 2008, 49:2545-2556.
39. Linja M.J., Savinainen K.J., Tammela T.L., Isola J.J., Visakorpi T. Expression of ERalpha and ERbeta in prostate cancer. Prostate 2003, 55:180-186.
40. Luft S., Milki E.A., Glustrom E., Ampiah-Bonney R., O'Hara P.B. Binding of organochloride and pyrethroid pesticides to estrogen receptors α and β: a fluorescence polarization assay. Biophysical. J. 2009, 96:444a.
41. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2Delta Delta C(T)) Method. Methods 2001, 25:402-408.
42. Lima K.M.G., Bedia C., Tauler R. A non-target chemometric strategy applied to UPLC-MS sphingolipid analysis of a cell line exposed to chlorpyrifos pesticide: a feasibility study. Microchem. J. 2014, 117:255-261.
43. Lopez-Espinosa M.J., Granada A., Carreno J., Salvatierra M., Olea-Serrano F., Olea N. Organochlorine pesticides in placentas from Southern Spain and some related factors. Placenta 2007, 28:631-638.
44. Murugesan P., Senthilkumar J., Balasubramanian K., Aruldhas M.M., Arunakaran J. Impact of polychlorinated biphenyl Aroclor 1254 on testicular antioxidant system in adult rats. Hum. Exp. Toxicol. 2005, 24:61-66.
45. Merrill A.H., Sullards M.C., Allegood J.C., Kelly S., Wang E. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005, 36:207-224.
46. Martinez W.L., Martinez A.R., Solka J.L. Exploratory Data Analysis with MATLAB 2011, CRC Press. Taylor & Francis Group, Boca Raton.
47. Matthews B.W. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim. Biophys. Acta 1975, 405:442-451.
48. Mills G.B., Moolenaar W.H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 2003, 3:582-591.
49. Prins G.S., Birch L., Tang W.Y., Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod. Toxicol. 2007, 23:374-382.
50. Prins G.S. Endocrine disruptors and prostate cancer risk. Endocr. Relat. Cancer 2008, 15:649-656.
51. Pere-Trepat E., Lacorte S., Tauler R. Solving liquid chromatography mass spectrometry coelution problems in the analysis of environmental samples by multivariate curve resolution. J. Chromatogr. A 2005, 1096:111-122.
52. Prins G.S., Hu W.Y., Shi G.B., Hu D.P., Majumdar S., Li G., Huang K., Nelles J.L., Ho S.M., Walker C.L., Kajdacsy-Balla A., van Breemen R.B. Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium. Endocrinology 2014, 155:805-817.
53. Pathak S., Meng W.J., Zhang H., Gnosa S., Nandy S.K., Adell G., Holmlund B., Sun X.F. Tafazzin protein expression is associated with tumorigenesis and radiation response in rectal cancer: a study of Swedish clinical trial on preoperative radiotherapy. PLoS One 2014, 9:e98317.
54. Qiu P., Plevritis S.K. TreeVis: a MATLAB-based tool for tree visualization. Comput. Methods Programs Biomed. 2013, 109:74-76.
55. Selvakumar K., Sheerin Banu L., Krishnamoorthy G., Venkataraman P., Elumalai P., Arunakaran J. Differential expression of androgen and estrogen receptors in PCB (Aroclor 1254)-exposed rat ventral prostate: impact of alpha-tocopherol. Exp. Toxicol. Pathol. 2011, 63:105-112.
56. Saunders M., Magnanti B.L., Correia Carreira S., Yang A., Alamo-Hernandez U., Riojas-Rodriguez H., Calamandrei G., Koppe J.G., Krayer von Krauss M., Keune H., Bartonova A. Chlorpyrifos and neurodevelopmental effects: a literature review and expert elicitation on research and policy. Environ. Health 2012, 11(Suppl 1):S5.
57. Salama J., Chakraborty T.R., Ng L., Gore A.C. Effects of polychlorinated biphenyls on estrogen receptor-beta expression in the anteroventral periventricular nucleus. Environ. Health Perspect. 2003, 111:1278-1282.
58. Schulze A., Harris A.L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012, 491:364-373.
59. Strauss R., Bartek J., Lieber A. Analysis of EMT by flow cytometry and immunohistochemistry. Methods Mol. Biol. 2013, 1049:355-368.
60. Sud M., Fahy E., Cotter D., Brown A., Dennis E.A., Glass C.K., Merrill A.H., Murphy R.C., Raetz C.R., Russell D.W., Subramaniam S. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 2007, 35:D527-D532.
61. Schild L., Lendeckel U., Gardemann A., Wiswedel I., Schmidt C.A., Wolke C., Walther R., Grabarczyk P., Busemann C. Composition of molecular cardiolipin species correlates with proliferation of lymphocytes. Exp. Biol. Med. Maywood 2012, 237:372-379.
62. Tauler R. Multivariate curve resolution applied to second order data. Chemom. Intell. Lab. Syst. 1995, 30:133-146.
63. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
64. Tarapore P., Ying J., Ouyang B., Burke B., Bracken B., Ho S.M. Exposure to bisphenol A correlates with early-onset prostate cancer and promotes centrosome amplification and anchorage-independent growth in vitro. PLoS One 2014, 9:e90332.
65. Taki T., Ishikawa D., Ogura M., Nakajima M., Handa S. Ganglioside GD1alpha functions in the adhesion of metastatic tumor cells to endothelial cells of the target tissue. Cancer Res. 1997, 57:1882-1888.
66. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., Djoumbou Y., Mandal R., Aziat F., Dong E., Bouatra S., Sinelnikov I., Arndt D., Xia J., Liu P., Yallou F., Bjorndahl T., Perez-Pineiro R., Eisner R., Allen F., Neveu V., Greiner R., Scalbert A. HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res. 2013, 41:D801-D807.
67. Wold S., Sjöström M., Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001, 58:109-130.
68. Wang H., Fang R., Wang X.F., Zhang F., Chen D.Y., Zhou B., Wang H.S., Cai S.H., Du J. Stabilization of Snail through AKT/GSK-3beta signaling pathway is required for TNF-alpha-induced epithelial-mesenchymal transition in prostate cancer PC3 cells. Eur. J. Pharmacol. 2013, 714:48-55.
69. Yeh C.R., Da J., Song W., Fazili A., Yeh S. Estrogen receptors in prostate development and cancer. Am. J. Clin. Exp. Urol. 2014, 2:161-168.
70. Yalcin S.S., Orun E., Yalcin S., Aykut O. Organochlorine pesticide residues in breast milk and maternal psychopathologies and infant growth from suburban area of Ankara, Turkey. Int. J. Environ. Health Res. 2014, 1-9.
71. Zani C., Toninelli G., Filisetti B., Donato F. Polychlorinated biphenyls and cancer: an epidemiological assessment. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2013, 31:99-144.
72. Zhang T., Saghatelian A. Emerging roles of lipids in BCL-2 family-regulated apoptosis. Biochim. Biophys. Acta 2013, 1831:1542-1554.
73. Zadra G., Photopoulos C., Loda M. The fat side of prostate cancer. Biochim. Biophys. Acta 2013, 1831:1518-1532.